Literature DB >> 14720613

A comparison of the fertile phase as determined by the Clearplan Easy Fertility Monitor and self-assessment of cervical mucus.

Richard J Fehring1, Kathleen Raviele, Mary Schneider.   

Abstract

The purpose of this study was to compare the fertile phase of the menstrual cycle as determined by the Clearplan Easy Fertility Monitor (CPEFM) with self-monitoring of cervical mucus. One-hundred women (mean age = 29.4 years) observed their cervical mucus and monitored their urine for estrogen and luteinizing hormone metabolites with the CPEFM on a daily basis for 2-6 cycles and generated 378 cycles of data; of these, 347 (92%) had a CPEFM peak. The beginning of the fertile window was, on average, day 11.8 (SD = 3.4) by the monitor and day 9.9 (SD = 3.0) by cervical mucus (r = 0.43, p < 0.001). The average first day of peak fertility by the monitor was 16.5 (SD = 3.6) and by cervical mucus 16.3 (SD = 3.7) (r = 0.85, p < 0.001). The mean length of the fertile phase by the monitor was 7.7 days (SD = 3.1) and by cervical mucus 10.9 days (SD = 3.7) (t = 12.7, p < 0.001). The peak in fertility as determined by the monitor and by self-assessment of cervical mucus is similar but the monitor tends to underestimate and self-assessment of cervical mucus tends to overestimate the actual fertile phase.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14720613     DOI: 10.1016/j.contraception.2003.09.011

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  6 in total

Review 1.  Current Medical ResearchWinter/Spring 2014.

Authors:  Richard J Fehring
Journal:  Linacre Q       Date:  2015-02

2.  Physiological signs of ovulation and fertility readily observable by women.

Authors:  Martin Owen
Journal:  Linacre Q       Date:  2013-02

3.  Cervical mucus monitoring prevalence and associated fecundability in women trying to conceive.

Authors:  Emily Evans-Hoeker; David A Pritchard; D Leann Long; Amy H Herring; Joseph B Stanford; Anne Z Steiner
Journal:  Fertil Steril       Date:  2013-07-11       Impact factor: 7.329

4.  Hormonal Contraception and the Informed Consent.

Authors:  David J Hilger; Kathleen M Raviele; Teresa A Hilgers
Journal:  Linacre Q       Date:  2018-12-04

5.  The Home Observation of Periconceptional Exposures (HOPE) study, a prospective cohort: aims, design, recruitment and compliance.

Authors:  Christina A Porucznik; Kyley J Cox; Karen C Schliep; Diana G Wilkins; Joseph B Stanford
Journal:  Environ Health       Date:  2016-06-08       Impact factor: 5.984

6.  Compliance with daily, home-based collection of urinary biospecimens in a prospective, preconception cohort.

Authors:  Kyley J Cox; Joseph B Stanford; Brenna E Blackburn; Christina A Porucznik
Journal:  Environ Epidemiol       Date:  2019-06-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.